Cibus Q1 net loss $27.0M; cash runway into Q3 2024; EU regulatory progress and wheat platform breakthrough

Cibus, Inc.

2024-Q1 EPS reported -$1.12 revenue$545,000

Net loss $27.0M ($1.12 per share) vs $5.4M in prior period; year-over-year not comparable due to business combination.
Cash and equivalents $24.5M; existing funds expected to cover operations only into Q3 2024 without new financing.
R&D expense $12.0M (up $9.8M) and SG&A $7.0M (up $4.7M), driven by headcount, stock comp, and facility costs.
EU Parliament voted to support NGT regulation similar to conventional breeding; wheat single-cell regeneration completed.
Signed three rice trait agreements (Loveland Products, Interoc); soybean platform expected operational in 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Cibus, Inc. reported financial results for the quarter ended March 31, 2024.

Period: the quarter ended March 31, 2024
Result: reported results

Exact text from the filing

Cibus, Inc. (the “Company”) announced its financial results for the three months ended March 31, 2024.

View on SEC.gov

1052 earnings releases filed in the last 30 days. Browse all earnings releases →

Cibus, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-022216

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.